HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication published in Business Standard (English) and Vijayawani (Kannada) on February 04, 2021 with regard to Board Meeting Notice dated February 03, 2021. HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Intimation Of Board Meeting
Healthcare Global Enterprises Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve and take on record the Unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31, 2020 ('Unaudited Financial Results'). Further, an Earnings Conference Call has been scheduled on Thursday, February 11, 2021, at 5.30 p.m. (IST), to discuss the Unaudited Financial Results. HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
Healthcare Global Enterprises Limited has informed the Exchange regarding a press release dated February 02, 2021, titled "Change in the CEO of the Company". Mr. Raj Gore has joined the Company as the CEO and KMP of the Company, on February 01, 2021. Healthcare Global Enterprises Limited has informed the Exchange regarding Resignation of Dr. B S Ajaikumar as Chief Executive Officer of the company w.e.f. February 01, 2021. HealthCare Global Enterprises Ltd - 539787 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate from Registrar and Share Transfer Agent under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. HealthCare Global Enterprises Ltd - 539787 - Intimation Regarding Submission Of Application For Reclassification Of Certain Individuals From Promoter And Promoter Group To Public Category
The Company has made an application to National Stock Exchange of India Limited and BSE Limited, for reclassification of certain individuals from Promoter and Promoter Group to Public category, in accordance with Regulation 31A of SEBI (LODR) Regulations, 2015. HealthCare Global Enterprises Ltd - 539787 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sunu ManuelDesignation :- Company Secretary and Compliance Officer HealthCare Global Enterprises Ltd - 539787 - Shareholding for the Period Ended December 31, 2020
HealthCare Global Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here HealthCare Global Enterprises Ltd - 539787 - Voting Results
Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Disclosure of voting results of Postal Ballot of HealthCare Global Enterprises Limited ('the Company'). HealthCare Global Enterprises Ltd - 539787 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
HealthCare Global Enterprises Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here HealthCare Global Enterprises Ltd - 539787 - Continuation Of The Office Of Dr. B.S. Ajaikumar As The CEO Of The Company Till January 31, 2021, In Accordance With The Investment Agreement Entered Into By And Between The Company, Aceso Company Pte. Ltd., Singapore ('Investor') And Dr. B.S. Ajaikumar, ('Promoter') On June 04, 2020 ('Investment Agreement')
We wish to inform you that, the Board of Directors of the Company ('Board') on December 30, 2020, has taken on record the consent of the parties to the Investment Agreement, to continue the term of office of Dr. B.S. Ajaikumar as the CEO of the Company, till January 31, 2021. Thereafter, he shall continue as a Whole-time Director and Chairman of the Board.